Including serous ovarian cancers only, we also observed an increased mean staining intensity of ERRγ in FIGO stages III and IV (2.27) than in FIGO staged I or II tumors (1.93) (p = 0.47) (Table 2b). This evidence concerns the gene ESRRG and ovarian serous adenocarcinoma.